Sign inJoin waitlistJoin the waitlist

Michael Khodadoust

Internal Medicine · Stanford Health Care

Credentials: · · · · ·

History

Stanford University
Until 2015
Stanford University
Until 2012
Stanford University
Until 2011
University of Michigan Health System
2010

Research

Determining cell type abundance and expression from bulk tissues with digital cytometry
Nature Biotechnology · 2019 · 3,521 citations
Profiling Tumor Infiltrating Immune Cells with CIBERSORT
Methods in molecular biology · 2018 · 3,201 citations
Early Detection of Molecular Residual Disease in Localized Lung Cancer by Circulating Tumor DNA Profiling
Cancer Discovery · 2017 · 877 citations

YK
Youn-Hee Kim
39 papers
Ash Alizadeh
18 papers
David Kurtz
13 papers
Sebastian Fernandez-Pol
11 papers · 4 as a fellow
Wen-Kai Weng
11 papers
Richard Hoppe
10 papers
BS
Brian Sworder
9 papers · 2 as a fellow
Maximilian Diehn
9 papers
Ronald Levy
9 papers
EW
Erica Wang
8 papers · 6 as a resident
Kerri Rieger
8 papers
DM
David Markovitz
6 papers

Grants

Immune Targeting of Non-Hodgkin Lymphoma Through Integrative Antigen Presentation Profiling
National Cancer Institute · K08
Contact PI · $867.7K · Stanford University
2018–2023

Clinical trials

Testing the Addition of an Anti-cancer Drug, Hu5F9-G4 (Magrolimab), to the Usual Chemotherapy Treatment (Mogamulizumab) in T-Cell (a Type of Immune Cell) Lymphoma That Has Returned After Treatment or Does Not Respond to Treatment
Principal investigator · Terminated · Phase 1, Phase 2
National Cancer Institute (NCI)
2021–2024
Testing the Combination of Two Experimental Drugs MK-3475 (Pembrolizumab) and Interferon-gamma for the Treatment of Mycosis Fungoides and Sézary Syndrome and Advanced Synovial Sarcoma
Principal investigator · Completed · Phase 2
National Cancer Institute (NCI)
2017–2023
TLR9 Agonist SD-101, Ibrutinib, and Radiation Therapy in Treating Patients With Relapsed or Refractory Grade 1-3A Follicular Lymphoma
Principal investigator · Completed · Phase 1, Phase 2
Robert Lowsky
2016–2023